https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/mds-aml-a-risk-with-parp-inhibitors-in-brca-mutation-carriers/ Mon, 20 May 2019 15:42:06 +0000 hourly 1 https://wordpress.org/?v=6.4.3